Using information on serum prostate specific antigen (PSA) level, tumour stage (T-stage) and Gleason grade allows stratification into three major groups (low-risk, intermediate-risk and high-risk) based on probability of biochemical recurrence after local therapy [6]. The gene discussed is KLK3; the disease is neoplasm.